• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
    • Calendar of Events
  • Our Programs
    • COVID 19
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
      • Active Drug Safety Monitoring and Management (aDSM) Program
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches
    • Official Publications
      • Drug Price Reference Index Booklet
      • National Antibiotic Guidelines
      • The Philippine Action Plan to Combat Antimicrobial Resistance 2019-2023
      • Philippine National Formulary
      • Progress Report
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
    • Calendar of Events
  • Our Programs
    • COVID 19
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
      • Active Drug Safety Monitoring and Management (aDSM) Program
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches
    • Official Publications
      • Drug Price Reference Index Booklet
      • National Antibiotic Guidelines
      • The Philippine Action Plan to Combat Antimicrobial Resistance 2019-2023
      • Philippine National Formulary
      • Progress Report
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

7th DOH Steering Committee Meeting for the Clinical Trials on COVID-19

Today, the DOH Steering Committee for the Conduct of Clinical Trials for investigational treatment for COVID-19 convenes to discuss updates regarding the clinical trials for investigational products (IPs) for COVID-19. continue reading : 7th DOH Steering Committee Meeting for the Clinical Trials on COVID-19

11th Policy Dialogue on Universal Healthcare and Access to Medicines

The Social Media Card that was used in the 11th Policy Dialogue on Universal Healthcare and Access to Medicines The DOH – Pharmaceutical Division (PD), in coordination with the Medicines continue reading : 11th Policy Dialogue on Universal Healthcare and Access to Medicines

DOH Imposes Mark-up Regulation on Essential Medicines

Administrative Order 2020-0043 The Department of Health (DOH) has recently issued the Administrative Order No. 2020-0043 entitled, “Guidelines on Ensuring the Affordability of Essential Medicines in DOH Facilities Through the continue reading : DOH Imposes Mark-up Regulation on Essential Medicines